PanaTimes

Monday, Dec 05, 2022
TV

Johnson & Johnson Announces Positive Covid Booster Data

Johnson & Johnson Announces Positive Covid Booster Data

A second shot given 56 days after the first provided 75 percent protection against symptomatic Covid in a global clinical trial, with that level rising to 94 percent in the United States.
*Your email address will not be displayed on website
This article does not have any comments yet.
PanaTimes
0:00
×